Clinical trial
Efficacy of Combination of Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post Mastectomy Complex Regional Pain Syndrome, Randomized Controlled Study.
NCT06033456 is registered in ClinicalTrials.gov with National Cancer Institute, Egypt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Combination of Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post Mastectomy Complex Regional Pain Syndrome, Randomized Controlled Study.
- Lead sponsor
- National Cancer Institute, Egypt
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 7, 2023
- Completion date
- March 15, 2024
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
complex regional pain syndromes, mastectomy, radiofrequency ablation, stellate ganglion